Benzodiazepine receptor agonists and inverse agonists yield concordant rather than opposing effects on startle responses

Journal of Psychopharmacology

Volumn 10, Issue 4, 1996, Pages 309-312

  Berntson, G ^a   Sarter, M ^a   Ruland, S ^a   Hart, S ^a   Ronis, V ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

carbolines; Benzodiazepines; Chlordiazepoxide; FG7142; Startle response

Indexed keywords

BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORDIAZEPOXIDE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; STARTLE REFLEX;

EID: 0030459030     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119601000409     Document Type: Article

References (25)

1. Berg W K, Davis M (1984) Diazepam blocks fear-enhanced startle elicited electrically from the brainstem. Physiol Behav 32: 333-336
2. Berntson G G, Hart S, Ruland S, Sarter M (1996) A central cholinergic link in the cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142. Behav Brain Res 74: 91-103
3. Braestrup C, Schmiechen R, Neef G, Nielson M, Petersen E N (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216: 1241-1243
4. Braestrup C, Honore T, Nielson M, Petersen E N, Jensen L H (1984) Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem Pharmacol 33: 859-862
5. Bruno J P, Miller J A (1995) Inhibition of GABAergic transmission: interactions with other transmitter systems. In Sarter M, Nutt D J, Lister R G (eds), Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp. 185-212
6. Davis M (1992) The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci 13: 35-41
7. Davis M, Falls W A, Campeau S, Munsoo K (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58: 175-198
8. Duka T, Dorow R (1995) Human experimental psychopharmacology of benzodiazepine receptor inverse agonists and antagonists. In Sarter M, Nutt D J, Lister R G (eds), Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp. 243-270
9. Faneslow M S, Helmstetter F J, Calcagnetti D J (1991) Parallels between the behavioral effects of dimethoxy-beta-carboline (DMCM) and conditioned fear stimuli. In Dachowski L, Flaherty C F (eds), Current topics in animal learning: brain, emotion, and cognition. Lawrence Erlbaum, Hillsdale, NJ, pp. 187-206
10. Haefely W E (1989) Pharmacology of allosteric modulation of GABAA receptors by benzodiazepine receptor ligands. In Barnard E A, Costa E (eds), Allosteric modulation of amino acid receptors: therapeutic implications. Raven Press, New York, pp. 47-69
11. Hijzen T H, Slangen J L (1989) Effects of midazolam, DMCM and lindane on potentiated startle in the rat. Psychopharmacology 99: 362-365
12. Hijzen T H, Houtzager S W J, Joordens R J E, Oliver B, Slangen J L (1995) Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology 118: 150-154
13. Holley L A, Turchi J, Apple C, Sarter M (1995) Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacology 120: 99-108
14. Moore H, Sarter M, Bruno J P (1993) Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 627: 267-274
15. Moore H, Sarter M, Bruno J P (1995) Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain. Neurosci Lett 198: 31-34
16. Petersen E, Jensen L H (1984) Proconflict effect of benzodiazepine inverse agonists and other inhibitors of GABA function. Eur J Pharmacol 103: 91-97
17. Piret B, Depaulis A, Vergnes M (1991) Opposite effects of agonist and inverse agonist ligands of benzodiazepine receptor on selfdefensive and submissive postures in the rat. Psychopharmacology 103: 56-61
18. Quigley K S, Sarter M F, Hart S L, Berntson G G (1994) Cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG7142 in rats. Behav Brain Res 62: 11-20
19. Sanger D J, Cohen C (1995) Fear and anxiety induced by benzodiazepine receptor inverse agonists. In Sarter M, Nutt D J, Lister R G (eds), Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp. 185-212
20. Sarter M, Nutt D J, Lister R G (eds) (1995) Benzodiazepine receptor inverse agonists. Wiley-Liss, New York
21. Sieghart W (1995) Subpopulations of benzodiazepine receptors: implications for the pharmacology of inverse agonists. In Sarter M, Nutt D J, Lister R G (eds), Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp. 1-24
22. Stephens D N, Jensen L H (eds) (1987) Bidirectional effects of β-carbolines in behavioral pharmacology. Brain Res Bull 19 (special issue)
23. Stephens D N, Shearman G T, Kehr W (1984) Discriminative stimulus properties of β-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors. Psychopharmacology 83: 233-239
24. Taylor S C, Little H J, Nutt D J, Sellars N (1985) A benzodiazepine agonist and contragonist have hypothermic effects in rodents. Neuropharmacology 24: 69-73
25. Thiebot M H, Dangoumau L, Richard G, Puech A J (1991) Safety signal withdrawal: a behavioral paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions. Psychopharmacology 103: 415-424